IDH2 and oligodendroglioma: Venteicher A.S. et al. dissected the intracellular heterogeneity at the single-cell level by comparing 14,226 scRNA-seq profiles with bulk RNA-seq derived from 165 patients, identifying a distinct tumor microenvironment composition that distinguished IDH-mutant oligodendrogliomas and astrocytomas [136].